Loading provider…
Loading provider…
Pulmonary Disease Physician in Kansas City, KS
NPI: 1396814430Primary Practice Location
UNIVERSITY OF KANSAS HOSPITAL
4000 Cambridge St, Kansas City, KS
Primary Employer
Ku Internal Medicine
kansashealthsystem.com
HQ Phone
Get MD Joel's Phone NumberMobile
Get MD Joel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 84 | 84 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 82 | 84 |
| 3 | 94726Determination of lung volumes using plethysmography | 69 | 69 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 62 | 85 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 56 | 119 |
HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis.
Authors: Mermis, Joel D, Simpson, Steven Q
Journal: Curr Infect Dis Rep
Authors: Derek Low
Journal: Ann Am Thorac Soc
Physical Activity Level and Perception of Exercise in Cystic Fibrosis.
Authors: Burnett, David M, Barry, Ashley N, Mermis, Joel D
Journal: Respir Care
Publication Date: 2020-01-28
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebos, DRUG: CB-280
Lead Sponsor: Savara Inc.
Intervention / Treatment: DRUG: Vancomycin inhalation powder, DRUG: Placebo inhalation powder
Lead Sponsor: Celtaxsys, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CTX-4430